Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Life-threatening bleeding, which remains a challenging complication of acute leukaemia, is particularly characteristic of the subtype, acute promyelocytic leukaemia (APL). The clinical picture and laboratory abnormalities are most compatible with the diagnosis of disseminated intravascular coagulation (DIC). Evidence for diffuse activation of the coagulation system, hyperfibrinolysis and systemic elaboration of non-specific protease activity can usually be demonstrated and occurs most commonly during induction chemotherapy. While both host- and tumour-associated mechanisms can be implicated in the pathogenesis of the coagulopathy, leukaemic cell properties appear to be the proximate cause of activation of the haemostatic mechanisms. In this chapter we summarize the current state of knowledge of the pathogenesis of the coagulopathy of APL and the therapeutic approaches that have proved most useful for the management of this complication. Special attention is devoted to the use of all-trans-retinoic acid (ATRA), which has revolutionized the treatment of APL and markedly ameliorated the APL-related coagulopathy.
Falanga
Anna
A
Hematology-Oncology Department, Ospedali Riuniti di Bergamo, Largo Barozzi 1, 24128, Bergamo, Italy. annafalanga@yahoo.com
Rickles
Frederick R
FR
D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy; D006474:Hemorrhagic Disorders / Q000209:etiology* / Q000628:therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D017713:Platelet Transfusion; D014212:Tretinoin / Q000627:therapeutic use
D014212:Tretinoin; D006493:Heparin